Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Vertex Pharmaceuticals (NQ: VRTX )

471.12 -4.86 (-1.02%)
Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,352,752
Open 471.06
Bid (Size) 465.00 (1)
Ask (Size) 473.47 (1)
Prev. Close 475.98
Today's Range 463.14 - 475.73
52wk Range 341.93 - 510.63
Shares Outstanding 259,428,394
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Thinking of Buying CRISPR Therapeutics Stock? Watch These 2 Key Numbers
It won't be able to be profitable without hitting its targets for both of these figures. 
Via The Motley Fool
As Stock Market Awaits Election, Palantir, S&P 500 Nuke Leaders Report
Amid the election, and a Fed rate vote, earnings season roars ahead. 
Via Investor's Business Daily
Topics Economy Stocks
Exposures Interest Rates US Equities

Performance

YTD
+14.65%
+14.65%
1 Month
+3.87%
+3.87%
3 Month
-1.21%
-1.21%
6 Month
+17.05%
+17.05%
1 Year
+25.23%
+25.23%

More News

Read More
Jim Cramer: This Financial Stock Is 'One Of The Most Consistent, Great Companies'
Via Benzinga
Vertex to Participate in Upcoming November Investor Conferences
From Vertex Pharmaceuticals Incorporated
Via Business Wire
Looking Into Vertex Pharmaceuticals's Recent Short Interest
Via Benzinga
Market Whales and Their Recent Bets on VRTX Options
Via Benzinga
Here's How Much You Would Have Made Owning Vertex Pharmaceuticals Stock In The Last 5 Years
Via Benzinga
These 10 Stocks Were The Best S&P 500 Performers In 2017 When Trump Was President: Will History Repeat Itself?
Via Benzinga
Topics Government Stocks
Exposures Political US Equities
12 High-Growth Stocks That Could Deliver Parabolic Returns
Via The Motley Fool
Vertex Provides Updates on Multiple Kidney Programs at the American Society of Nephrology (ASN) Annual Kidney Week Congress
From Vertex Pharmaceuticals Incorporated
Via Business Wire
The Smartest Growth Stock to Buy With $500 Right Now
Via The Motley Fool
Vertex Pharmaceuticals Just Found Its Newest Blockbuster Drug. A $41 Billion Market Awaits
Via The Motley Fool
Why We Buy Stocks
Via The Motley Fool
Prediction: These 2 Stocks Will Beat the S&P 500 Through 2030
Via The Motley Fool
Topics Stocks
Exposures US Equities
Vertex to Present Phase 3 Data Highlighting Suzetrigine’s Potential as a First-in-Class, Highly Selective Pain Signal Inhibitor at the American Society of Anesthesiologists Annual Meeting
From Vertex Pharmaceuticals Incorporated
Via Business Wire
Vertex Pharmaceuticals Stock: A Deep Dive Into Analyst Perspectives (19 Ratings)
Via Benzinga
Here's How Much $1000 Invested In Vertex Pharmaceuticals 5 Years Ago Would Be Worth Today
Via Benzinga
Got $1,000? 2 Magnificent Growth Stocks to Buy and Hold Forever
Via The Motley Fool
3 No-Brainer Growth Stocks to Buy in October
Via The Motley Fool
Vertex to Announce Third Quarter 2024 Financial Results on November 4th
From Vertex Pharmaceuticals Incorporated
Via Business Wire
Biden Administration Unveils Plan To Provide Generic Drugs for $2 to Medicare Recipients
Via Benzinga
2 Biotech Stocks to Buy Hand Over Fist in October
Via The Motley Fool
Cathie Wood's Ark Invest Trades: Bets $14M On Amazon Shares — Dumps Robinhood Stock Worth $36M, Embraces Coinbase And Meta
Via Benzinga
S&P 500 Could Reach 6,300 In 12 Months, Says Goldman Sachs, Driven By 'Strong AI Demand' And 'Margin Expansion'
Via Benzinga
Topics Artificial Intelligence Stocks
Exposures Artificial Intelligence US Equities
Insider Trades: How To Find The Top Stocks
Via Talk Markets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.